Choroidal Neovascularization Market Report

Global Choroidal Neovascularization Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 11, 2022
  • PAGES：205
  • REPORT CODE：GMM820328
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Choroidal Neovascularization market report explains the definition, types, applications, major countries, and major players of the Choroidal Neovascularization market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Promedior Inc

    • QLT Inc

    • Gilead Sciences Inc

    • Bayer AG

    • Valeant Pharmaceuticals International Inc

    • Novartis AG

    • Regeneron Pharmaceuticals Inc

    • Pfizer Inc

    • Sanwa Kagaku Kenkyusho Co Ltd

    • F Hoffmann-La Roche Ltd

    By Type:

    • Intravenous

    • Intravitreal

    By End-User:

    • Extreme Myopia

    • Malignant Myopic Degeneration

    • Age-Related Developments

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Choroidal Neovascularization Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Choroidal Neovascularization Outlook to 2028- Original Forecasts

    • 2.2 Choroidal Neovascularization Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Choroidal Neovascularization Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Choroidal Neovascularization Market- Recent Developments

    • 6.1 Choroidal Neovascularization Market News and Developments

    • 6.2 Choroidal Neovascularization Market Deals Landscape

    7 Choroidal Neovascularization Raw Materials and Cost Structure Analysis

    • 7.1 Choroidal Neovascularization Key Raw Materials

    • 7.2 Choroidal Neovascularization Price Trend of Key Raw Materials

    • 7.3 Choroidal Neovascularization Key Suppliers of Raw Materials

    • 7.4 Choroidal Neovascularization Market Concentration Rate of Raw Materials

    • 7.5 Choroidal Neovascularization Cost Structure Analysis

      • 7.5.1 Choroidal Neovascularization Raw Materials Analysis

      • 7.5.2 Choroidal Neovascularization Labor Cost Analysis

      • 7.5.3 Choroidal Neovascularization Manufacturing Expenses Analysis

    8 Global Choroidal Neovascularization Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Choroidal Neovascularization Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Choroidal Neovascularization Export by Region (Top 10 Countries) (2017-2028)

    9 Global Choroidal Neovascularization Market Outlook by Types and Applications to 2022

    • 9.1 Global Choroidal Neovascularization Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Intravenous Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Intravitreal Consumption and Growth Rate (2017-2022)

    • 9.2 Global Choroidal Neovascularization Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Extreme Myopia Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Malignant Myopic Degeneration Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Age-Related Developments Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Choroidal Neovascularization Market Analysis and Outlook till 2022

    • 10.1 Global Choroidal Neovascularization Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Choroidal Neovascularization Consumption (2017-2022)

      • 10.2.2 Canada Choroidal Neovascularization Consumption (2017-2022)

      • 10.2.3 Mexico Choroidal Neovascularization Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Choroidal Neovascularization Consumption (2017-2022)

      • 10.3.2 UK Choroidal Neovascularization Consumption (2017-2022)

      • 10.3.3 Spain Choroidal Neovascularization Consumption (2017-2022)

      • 10.3.4 Belgium Choroidal Neovascularization Consumption (2017-2022)

      • 10.3.5 France Choroidal Neovascularization Consumption (2017-2022)

      • 10.3.6 Italy Choroidal Neovascularization Consumption (2017-2022)

      • 10.3.7 Denmark Choroidal Neovascularization Consumption (2017-2022)

      • 10.3.8 Finland Choroidal Neovascularization Consumption (2017-2022)

      • 10.3.9 Norway Choroidal Neovascularization Consumption (2017-2022)

      • 10.3.10 Sweden Choroidal Neovascularization Consumption (2017-2022)

      • 10.3.11 Poland Choroidal Neovascularization Consumption (2017-2022)

      • 10.3.12 Russia Choroidal Neovascularization Consumption (2017-2022)

      • 10.3.13 Turkey Choroidal Neovascularization Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Choroidal Neovascularization Consumption (2017-2022)

      • 10.4.2 Japan Choroidal Neovascularization Consumption (2017-2022)

      • 10.4.3 India Choroidal Neovascularization Consumption (2017-2022)

      • 10.4.4 South Korea Choroidal Neovascularization Consumption (2017-2022)

      • 10.4.5 Pakistan Choroidal Neovascularization Consumption (2017-2022)

      • 10.4.6 Bangladesh Choroidal Neovascularization Consumption (2017-2022)

      • 10.4.7 Indonesia Choroidal Neovascularization Consumption (2017-2022)

      • 10.4.8 Thailand Choroidal Neovascularization Consumption (2017-2022)

      • 10.4.9 Singapore Choroidal Neovascularization Consumption (2017-2022)

      • 10.4.10 Malaysia Choroidal Neovascularization Consumption (2017-2022)

      • 10.4.11 Philippines Choroidal Neovascularization Consumption (2017-2022)

      • 10.4.12 Vietnam Choroidal Neovascularization Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Choroidal Neovascularization Consumption (2017-2022)

      • 10.5.2 Colombia Choroidal Neovascularization Consumption (2017-2022)

      • 10.5.3 Chile Choroidal Neovascularization Consumption (2017-2022)

      • 10.5.4 Argentina Choroidal Neovascularization Consumption (2017-2022)

      • 10.5.5 Venezuela Choroidal Neovascularization Consumption (2017-2022)

      • 10.5.6 Peru Choroidal Neovascularization Consumption (2017-2022)

      • 10.5.7 Puerto Rico Choroidal Neovascularization Consumption (2017-2022)

      • 10.5.8 Ecuador Choroidal Neovascularization Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Choroidal Neovascularization Consumption (2017-2022)

      • 10.6.2 Kuwait Choroidal Neovascularization Consumption (2017-2022)

      • 10.6.3 Oman Choroidal Neovascularization Consumption (2017-2022)

      • 10.6.4 Qatar Choroidal Neovascularization Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Choroidal Neovascularization Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Choroidal Neovascularization Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Choroidal Neovascularization Consumption (2017-2022)

      • 10.7.2 South Africa Choroidal Neovascularization Consumption (2017-2022)

      • 10.7.3 Egypt Choroidal Neovascularization Consumption (2017-2022)

      • 10.7.4 Algeria Choroidal Neovascularization Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Choroidal Neovascularization Consumption (2017-2022)

      • 10.8.2 New Zealand Choroidal Neovascularization Consumption (2017-2022)

    11 Global Choroidal Neovascularization Competitive Analysis

    • 11.1 Promedior Inc

      • 11.1.1 Promedior Inc Company Details

      • 11.1.2 Promedior Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Promedior Inc Choroidal Neovascularization Main Business and Markets Served

      • 11.1.4 Promedior Inc Choroidal Neovascularization Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 QLT Inc

      • 11.2.1 QLT Inc Company Details

      • 11.2.2 QLT Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 QLT Inc Choroidal Neovascularization Main Business and Markets Served

      • 11.2.4 QLT Inc Choroidal Neovascularization Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Gilead Sciences Inc

      • 11.3.1 Gilead Sciences Inc Company Details

      • 11.3.2 Gilead Sciences Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Gilead Sciences Inc Choroidal Neovascularization Main Business and Markets Served

      • 11.3.4 Gilead Sciences Inc Choroidal Neovascularization Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Bayer AG

      • 11.4.1 Bayer AG Company Details

      • 11.4.2 Bayer AG Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Bayer AG Choroidal Neovascularization Main Business and Markets Served

      • 11.4.4 Bayer AG Choroidal Neovascularization Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Valeant Pharmaceuticals International Inc

      • 11.5.1 Valeant Pharmaceuticals International Inc Company Details

      • 11.5.2 Valeant Pharmaceuticals International Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Valeant Pharmaceuticals International Inc Choroidal Neovascularization Main Business and Markets Served

      • 11.5.4 Valeant Pharmaceuticals International Inc Choroidal Neovascularization Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Novartis AG

      • 11.6.1 Novartis AG Company Details

      • 11.6.2 Novartis AG Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Novartis AG Choroidal Neovascularization Main Business and Markets Served

      • 11.6.4 Novartis AG Choroidal Neovascularization Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Regeneron Pharmaceuticals Inc

      • 11.7.1 Regeneron Pharmaceuticals Inc Company Details

      • 11.7.2 Regeneron Pharmaceuticals Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Regeneron Pharmaceuticals Inc Choroidal Neovascularization Main Business and Markets Served

      • 11.7.4 Regeneron Pharmaceuticals Inc Choroidal Neovascularization Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Pfizer Inc

      • 11.8.1 Pfizer Inc Company Details

      • 11.8.2 Pfizer Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Pfizer Inc Choroidal Neovascularization Main Business and Markets Served

      • 11.8.4 Pfizer Inc Choroidal Neovascularization Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Sanwa Kagaku Kenkyusho Co Ltd

      • 11.9.1 Sanwa Kagaku Kenkyusho Co Ltd Company Details

      • 11.9.2 Sanwa Kagaku Kenkyusho Co Ltd Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Sanwa Kagaku Kenkyusho Co Ltd Choroidal Neovascularization Main Business and Markets Served

      • 11.9.4 Sanwa Kagaku Kenkyusho Co Ltd Choroidal Neovascularization Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 F Hoffmann-La Roche Ltd

      • 11.10.1 F Hoffmann-La Roche Ltd Company Details

      • 11.10.2 F Hoffmann-La Roche Ltd Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 F Hoffmann-La Roche Ltd Choroidal Neovascularization Main Business and Markets Served

      • 11.10.4 F Hoffmann-La Roche Ltd Choroidal Neovascularization Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Choroidal Neovascularization Market Outlook by Types and Applications to 2028

    • 12.1 Global Choroidal Neovascularization Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Intravenous Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Intravitreal Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Choroidal Neovascularization Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Extreme Myopia Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Malignant Myopic Degeneration Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Age-Related Developments Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Choroidal Neovascularization Market Analysis and Outlook to 2028

    • 13.1 Global Choroidal Neovascularization Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.2.2 Canada Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Choroidal Neovascularization Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.3.2 UK Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.3.3 Spain Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.3.5 France Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.3.6 Italy Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.3.8 Finland Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.3.9 Norway Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.3.11 Poland Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.3.12 Russia Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Choroidal Neovascularization Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.4.2 Japan Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.4.3 India Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Choroidal Neovascularization Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.5.3 Chile Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.5.6 Peru Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Choroidal Neovascularization Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.6.3 Oman Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Choroidal Neovascularization Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Choroidal Neovascularization Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Choroidal Neovascularization Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Choroidal Neovascularization Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Choroidal Neovascularization

    • Figure of Choroidal Neovascularization Picture

    • Table Global Choroidal Neovascularization Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Choroidal Neovascularization Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Intravenous Consumption and Growth Rate (2017-2022)

    • Figure Global Intravitreal Consumption and Growth Rate (2017-2022)

    • Figure Global Extreme Myopia Consumption and Growth Rate (2017-2022)

    • Figure Global Malignant Myopic Degeneration Consumption and Growth Rate (2017-2022)

    • Figure Global Age-Related Developments Consumption and Growth Rate (2017-2022)

    • Figure Global Choroidal Neovascularization Consumption by Country (2017-2022)

    • Table North America Choroidal Neovascularization Consumption by Country (2017-2022)

    • Figure United States Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Canada Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Mexico Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Table Europe Choroidal Neovascularization Consumption by Country (2017-2022)

    • Figure Germany Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure UK Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Spain Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Belgium Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure France Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Italy Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Denmark Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Finland Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Norway Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Sweden Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Poland Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Russia Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Turkey Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Table APAC Choroidal Neovascularization Consumption by Country (2017-2022)

    • Figure China Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Japan Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure India Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure South Korea Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Thailand Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Singapore Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Philippines Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Table South America Choroidal Neovascularization Consumption by Country (2017-2022)

    • Figure Brazil Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Colombia Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Chile Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Argentina Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Peru Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Table GCC Choroidal Neovascularization Consumption by Country (2017-2022)

    • Figure Bahrain Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Oman Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Qatar Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Table Africa Choroidal Neovascularization Consumption by Country (2017-2022)

    • Figure Nigeria Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure South Africa Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Egypt Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Algeria Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Table Oceania Choroidal Neovascularization Consumption by Country (2017-2022)

    • Figure Australia Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Table Promedior Inc Company Details

    • Table Promedior Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table Promedior Inc Choroidal Neovascularization Main Business and Markets Served

    • Table Promedior Inc Choroidal Neovascularization Product Portfolio

    • Table QLT Inc Company Details

    • Table QLT Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table QLT Inc Choroidal Neovascularization Main Business and Markets Served

    • Table QLT Inc Choroidal Neovascularization Product Portfolio

    • Table Gilead Sciences Inc Company Details

    • Table Gilead Sciences Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Inc Choroidal Neovascularization Main Business and Markets Served

    • Table Gilead Sciences Inc Choroidal Neovascularization Product Portfolio

    • Table Bayer AG Company Details

    • Table Bayer AG Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Choroidal Neovascularization Main Business and Markets Served

    • Table Bayer AG Choroidal Neovascularization Product Portfolio

    • Table Valeant Pharmaceuticals International Inc Company Details

    • Table Valeant Pharmaceuticals International Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals International Inc Choroidal Neovascularization Main Business and Markets Served

    • Table Valeant Pharmaceuticals International Inc Choroidal Neovascularization Product Portfolio

    • Table Novartis AG Company Details

    • Table Novartis AG Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Choroidal Neovascularization Main Business and Markets Served

    • Table Novartis AG Choroidal Neovascularization Product Portfolio

    • Table Regeneron Pharmaceuticals Inc Company Details

    • Table Regeneron Pharmaceuticals Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals Inc Choroidal Neovascularization Main Business and Markets Served

    • Table Regeneron Pharmaceuticals Inc Choroidal Neovascularization Product Portfolio

    • Table Pfizer Inc Company Details

    • Table Pfizer Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Choroidal Neovascularization Main Business and Markets Served

    • Table Pfizer Inc Choroidal Neovascularization Product Portfolio

    • Table Sanwa Kagaku Kenkyusho Co Ltd Company Details

    • Table Sanwa Kagaku Kenkyusho Co Ltd Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanwa Kagaku Kenkyusho Co Ltd Choroidal Neovascularization Main Business and Markets Served

    • Table Sanwa Kagaku Kenkyusho Co Ltd Choroidal Neovascularization Product Portfolio

    • Table F Hoffmann-La Roche Ltd Company Details

    • Table F Hoffmann-La Roche Ltd Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Choroidal Neovascularization Main Business and Markets Served

    • Table F Hoffmann-La Roche Ltd Choroidal Neovascularization Product Portfolio

    • Figure Global Intravenous Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intravitreal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Extreme Myopia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Malignant Myopic Degeneration Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Age-Related Developments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Choroidal Neovascularization Consumption Forecast by Country (2022-2028)

    • Table North America Choroidal Neovascularization Consumption Forecast by Country (2022-2028)

    • Figure United States Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Choroidal Neovascularization Consumption Forecast by Country (2022-2028)

    • Figure Germany Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Choroidal Neovascularization Consumption Forecast by Country (2022-2028)

    • Figure China Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Choroidal Neovascularization Consumption Forecast by Country (2022-2028)

    • Figure Brazil Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Choroidal Neovascularization Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Choroidal Neovascularization Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Choroidal Neovascularization Consumption Forecast by Country (2022-2028)

    • Figure Australia Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US